What Researchers Did
Doctors reported a case of an 8-year-old boy who developed severe inflammation of both retinas following a mumps infection, and was treated with steroids and HBOT as a rescue therapy.
What They Found
The child had widespread retinal inflammation confirmed by MRI and elevated mumps antibodies. After standard steroid treatment was insufficient, HBOT was added as a rescue therapy. Improvement in vision was noted, with the left eye recovering better than the right. There is no specific antiviral drug available for mumps.
What This Means for Canadian Patients
For Canadian children who develop rare mumps-related eye complications, more likely in unvaccinated individuals, HBOT may offer additional benefit when steroids alone are not enough to protect vision. This case reinforces the importance of the measles-mumps-rubella (MMR) vaccination program in preventing these complications.
Canadian Relevance
No direct Canadian connection identified. Canada's public vaccine program covers MMR, making this complication rare in vaccinated populations.
Study Limitations
This is a single pediatric case report and the relative contributions of steroids versus HBOT to the visual improvement cannot be separated.